Evidence map›Paper›PMID 33915827›Full record

ArticleBiology2021

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth.

Alexandru Mester, Marioara Moldovan, Marian Taulescu, Codruta Sarosi, Ioan Petean, Adriana Vulpoi, Andra Piciu, Andrada Voina-Tonea, Cristina Moisescu-Goia, Elena Barbus and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Alexandru MesterDepartment of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.ORCID 0000-0002-3393-4307
Marioara MoldovanDepartment of Polymer Composites, Institute of Chemistry "Raluca Ripan", University Babes-Bolyai, 400294 Cluj-Napoca, Romania.ORCID 0000-0001-9714-4809
Marian TaulescuDepartment of Pathology, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.ORCID 0000-0002-8987-6038
Codruta SarosiDepartment of Polymer Composites, Institute of Chemistry "Raluca Ripan", University Babes-Bolyai, 400294 Cluj-Napoca, Romania.
Ioan PeteanDepartment of Chemistry and Chemical Engineering, University Babes-Bolyai, 400294 Cluj-Napoca, Romania.ORCID 0000-0003-3274-8817
Adriana VulpoiNanostructured Materials and Bio-Nano-Interfaces Center, Interdisciplinary Research, Institute of Bio-Nano-Sciences, University Babes-Bolyai, 400271 Cluj-Napoca, Romania.
Andra PiciuDepartment of Medical Oncology, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.
Andrada Voina-ToneaDepartment of Dental Materials, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.
Cristina Moisescu-GoiaDepartment of Endocrine Tumors and Nuclear Medicine, Oncology Institute "Ion Chiricuta", University of Medicine and Pharmacy "Iuliu Hatieganu, 400012 Cluj-Napoca, Romania.
Elena BarbusDepartment of Endocrine Tumors and Nuclear Medicine, Oncology Institute "Ion Chiricuta", University of Medicine and Pharmacy "Iuliu Hatieganu, 400012 Cluj-Napoca, Romania.
Doina PiciuDepartment of Endocrine Tumors and Nuclear Medicine, Oncology Institute "Ion Chiricuta", University of Medicine and Pharmacy "Iuliu Hatieganu, 400012 Cluj-Napoca, Romania.ORCID 0000-0001-6184-7449
Babeș-Bolyai University · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · ROIuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radioiodine-131 (I-131) is an essential therapy for patients with differentiated thyroid carcinomas (DTC). Generally, I-131 is safe and well tolerated, but patients may present early or late complications in the oral and maxillofacial areas. Thus, the aim of this study was to evaluate in-vitro, the alteration of enamel and dentin after I-131 exposure using histopathological assessment, scanning electron microscopy (SEM) and atomic force microscopy (AFM). For I-131 irradiation, an in-vitro protocol was used that simulates the procedure for irradiation therapy performed for patients with DTCs. A total of 42 teeth were divided into seven groups (n = 6) and irradiated as follows: control, irradiation groups (3, 6, 12, 36, 48 h, 8 days). Histological changes were observed at 48 h (enamel surface with multifocal and irregular areas) and at 8 days (enamel surface with multiple, very deep, delimited cavities). SEM imaging revealed the enamel destruction progresses along with the treatment time increasing. The alterations are extended into the enamel depth and the dislocated hydroxyapatite debris is overwhelming. The enamel-dentine interface shows small gaps after 6 h and a very well developed valley after 12 h; the interface microstructure resulted after 8 days is deeply altered. The AFM imaging shows that I-131 affects the protein bond between hydroxyapatite nano-crystals causing loss of cohesion, which leads to significant increasing of nano-particles diameter after 6 h. In conclusion, both enamel and dentin appear to be altered between 12 and 48 h and after 8 days of treatment are extended in depth.

Indexed as

dental structureI-131radioiodine-131

Identifiers

PMID33915827
PMCPMC8065707
OpenAlexW3152317186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.